21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
Related Articles
A Continuous Race of Biomarker Research and Molecular Strategies
Through prolific biomarker research, Fabrice André, MD, PhD, has worked throughout his career to make strides in personalized breast cancer care.
Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort study
The negative patient-reported effects associated with a CSD result from MCED testing were small and returned to baseline within 12 months for participants with or…
Insights on Extranodal Extension in Head and Neck Cancers
Christina Henson, MD, discussed some of the current imaging guidelines in head and neck cancer, with a focus on extranodal extension.
A Pragmatist’s View on Biomarker-Driven Decisions in Oncology: Episode 1
Website: https://www.onclive.comTwitter: https://twitter.com/OncLiveFacebook: https://www.facebook.com/OncLive/LinkedIn: https://www.linkedin.com/company/onc…
A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer
Acha-Sagredo et al. stratify colorectal cancers using features of an immune-reactive tumor microenvironment. This microenvironment, locally abundant in cytotoxic lymphocytes and antigen-presenting macrophages, facilitates immunotherapy response…
Revisit Every OncLive On Air Episode From December 2024
In case you missed any, read a recap of the episodes of OncLive On Air that aired in December 2024.
Genetic counseling comes to CH Hospital – The Chestnut Hill Local
Fox Chase Cancer Center has expanded its genetic counseling and high-risk breast cancer services to Temple Health – Chestnut Hill Hospital.
Blood Podcast | Blood | American Society of Hematology
Blood Podcast | Blood | American Society of Hematology Blood Podcast The editors of Blood are pleased to introduce a podcast series, published weekly…
NCCN publishes patient resource on genetic testing to guide patient decisionmaking – The Cancer Letter
The National Comprehensive Cancer Network published its first patient resource aimed at informing people about the latest recommendations around hereditary and familial cancer risk. The…
